📰 1 source covering this story

Moderna’s Shift to Cancer Company Lifts Stock Up 177%

Compare how each outlet is covering it — and rate the sources you trust.

The company’s fortunes cratered as demand for Covid-19 vaccines plummeted. But it was busy working on something else.